Inkwiy Kim, MD | |
1064 E Main St, Suite 302, Meriden, CT 06450-4898 | |
(203) 235-3345 | |
(203) 235-5658 |
Full Name | Inkwiy Kim |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 1064 E Main St, Meriden, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881626448 | NPI | - | NPPES |
060864650 | Other | CT | UNITED HEALTHCARE |
010018027CT01 | Other | CT | ANTHEM |
4539436 | Other | CT | AETNA |
ORO204 | Other | CT | HEALTHNET |
060864650 | Other | CT | CIGNA |
0180275663 | Other | CT | CONNECTICARE |
P381429 | Other | CT | OXFORD |
001180272 | Medicaid | CT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 018027 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Inkwiy Kim, MD 1064 E Main St, Suite 302, Meriden, CT 06450-4898 Ph: (203) 235-3345 | Inkwiy Kim, MD 1064 E Main St, Suite 302, Meriden, CT 06450-4898 Ph: (203) 235-3345 |
News Archive
An advisory panel for the US Food and Drugs Administration voted 9-6 that the FDA should not yet approve dapagliflozin, a new type of diabetes drug that makes the body dump sugar and lose weight. Signals of possible liver damage and of breast and bladder cancer worried the experts.
Cold season may be just behind us, but a new discovery may shed light on how this common condition triggers asthma attacks. In a new research report published in the June 2014 issue of the Journal of Leukocyte Biology, researchers show that in individuals with asthma, statins significantly reduce the in vitro inflammatory response of human monocytes to rhinovirus (RV), the cause of the common cold.
Researchers at UT Southwestern Medical Center at Dallas have completed the first comprehensive study of the effects of liposuction on different parts of the body during and immediately following the procedure.
Coordination of care designed to slow the progression of kidney disease is likely to be cost effective because it prevents the need for dialysis, according to a study that will be presented at ASN Kidney Week 2016 November 15¬-20 at McCormick Place in Chicago, IL.
› Verified 2 days ago